Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (611-620 of 4,678) with videos related to

Pageof 468
Sort By:
Cancer Discovery|November 27, 2015
CRUK Launches "Grand Challenges"Janet Colwell
Cancer Discovery|November 8, 2015
MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in MalignancyManish Neupane, Allison P Clark, Serena Landini, et al.
Cancer Discovery|December 12, 2013
Teaching an old dog new tricks: drug repositioning in small cell lung cancerJing Wang, Lauren Averett Byers
Cancer Discovery|December 12, 2013
Antibody-drug conjugate may inhibit pancreatic cancer
Cancer Discovery|December 12, 2013
Nanopharmaceutical may offer benefits in combinations
Cancer Discovery|December 12, 2013
Ramucirumab takes steps forward in gastric cancer
Cancer Discovery|December 12, 2013
Targeting resistance in lung cancer
Cancer Discovery|September 4, 2014
L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancerEun-Hee Shim, Carolina B Livi, Dinesh Rakheja, et al.
Cancer Discovery|September 4, 2014
Beleodaq approved for rare lymphomas
Cancer Discovery|September 4, 2014
A plan of attack for deadly cancers
Pageof 468

Showing results (611-620 of 4,678) with videos related to

Sort By:
Pageof 468
Cancer Discovery|November 27, 2015
CRUK Launches "Grand Challenges"Janet Colwell
Cancer Discovery|November 8, 2015
MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in MalignancyManish Neupane, Allison P Clark, Serena Landini, et al.
Cancer Discovery|December 12, 2013
Teaching an old dog new tricks: drug repositioning in small cell lung cancerJing Wang, Lauren Averett Byers
Cancer Discovery|December 12, 2013
Antibody-drug conjugate may inhibit pancreatic cancer
Cancer Discovery|December 12, 2013
Nanopharmaceutical may offer benefits in combinations
Cancer Discovery|December 12, 2013
Ramucirumab takes steps forward in gastric cancer
Cancer Discovery|December 12, 2013
Targeting resistance in lung cancer
Cancer Discovery|September 4, 2014
L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancerEun-Hee Shim, Carolina B Livi, Dinesh Rakheja, et al.
Cancer Discovery|September 4, 2014
Beleodaq approved for rare lymphomas
Cancer Discovery|September 4, 2014
A plan of attack for deadly cancers
Pageof 468